Clinical trial

Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study

NCT06649955

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-02-10

PhaseNA

Study timeline

Study start (actual)2025-02-10Date precision: day

Registry last updated2026-09-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

ALS - Amyotrophic Lateral Sclerosisunresolved

Interventions

Multi-site direct current stimulation (DCS)DEVICE

Sponsors & collaborators

PathMaker Neurosystems Inc.lead sponsor

Beth Israel Deaconess Medical Centercollaborator

United States Department of Defensecollaborator

Mapped research locations

BostonMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06649955 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.